PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture)

Launched by 21 CENTURY MEDICAL CO., LTD. · Jul 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a special type of thread called polydioxanone (PDO) used to gently lift and tighten the skin on the face without making any cuts. The goal is to see how safe and effective this thread is for improving the appearance of wrinkles and signs of aging, helping people look more refreshed and youthful.

People who are 18 years or older, able to understand the treatment, and willing to follow the study’s schedule may be eligible to join. However, pregnant or breastfeeding women, those currently in other studies, people recently vaccinated, or those with serious health problems like severe heart, liver, kidney, or nervous system conditions cannot participate. If you join, you can expect the procedure to be done without surgery, and you will have follow-up visits to check how well the treatment works and to make sure it is safe for you. This study is not recruiting yet but aims to provide important information about this non-surgical option for facial rejuvenation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18 years old with full legal capacity, male and female;
• • Patients with ability to understand the proposed aesthetic correction and to understand and sign informed consent;
• • Patients who are willing and able to comply with scheduled visits, aesthetic correction procedure and other trial procedures.
• Exclusion Criteria:
• • Pregnant or breast--feeding women;
• • Patients currently participating in any other clinical investigation;
• • Patients who have received a vaccine within 14 days prior to the baseline or plan to have vaccine within 14 days after the injection;
• • Patients with a medical history of systemic diseases, including severe kidney, liver, heart and neurological disorders.